Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

On the 11th March Oxford University and NHS researchers will showcase the latest innovations in technology at “Innovation in healthcare research” at The Martin School in heart of Oxford. The interactive exhibition starts at 12 pm until 6 pm and is free.

Leading researchers will be on hand to talk about the latest developments in biomedical informatics and technology, surgical innovations, and translational physiology. Visitors can also try their hand at interactive exhibitions to discover how technology is revolutionising healthcare both in the hospital and at home. There will also be a series of talks on innovative technology for healthcare given by University and Trust speakers.

Vasiliki Kiparoglou, Head of Operations, NIHR Oxford BRC said:

 “Oxford  has long been at the forefront of medical research, whether it is the genetic and molecular basis of disease, the latest advances in neuroscience, or clinical studies in cancer, diabetes, heart disease, stroke and other conditions. This is a fantastic opportunity for the public to learn about the benefits to patients of the latest developments in healthcare research.”

Exhibits include the first results in gene trails for inherited blindness, pioneering lung imaging techniques that may improve diagnosis and treatment, personalised mobile health for heart failure, prediction of physiological patterns in pregnancy and much more.

 “Innovation in healthcare research” is part of the NIHR Oxford BRC Open Weeks programme of talks, tours and exhibitions, which are taking place during “Oxfordshire Science Festival” and “British Science Week”

Similar stories

Risk of rare blood clotting higher for COVID-19 than for vaccines

Coronavirus COVID-19 Research

COVID-19 leads to a several-times higher risk of cerebral venous thrombosis (CVT) blood clots than current COVID-19 vaccines.

Asthma drug budesonide shortens recovery time in non-hospitalised patients with COVID-19

Clinical Trials Coronavirus COVID-19 Research

Inhaled budesonide, a common corticosteroid, is the first widely available, inexpensive drug found to shorten recovery times in COVID-19 patients aged over 50 who are treated at home and in other community settings, reports the PRINCIPLE trial in 1,779 participants.

AIMday in Women's Health - registration for academics now open

Events Innovation

Are you an academic interested in finding out how your knowledge can be used to solve industry challenges? Would you like to widen your network? Meet potential collaborators / future employees? Gain insights into relevant funding schemes? If you answer YES to any of the above, now is the time to register for the AIMday in Women's Health.

Link between COVID-19 infection and subsequent mental health and neurological conditions found

Coronavirus COVID-19 General Research

One in three COVID-19 survivors received a neurological or psychiatric diagnosis within six months of infection with the SARS-CoV-2 virus, an observational study of more than 230,000 patient health records published in The Lancet Psychiatry journal estimates. The study looked at 14 neurological and mental health disorders.

New national study of long-term impacts of debilitating lung damage from COVID-19

Coronavirus COVID-19 General Research

A new national study will investigate the long-term effects of lung inflammation and scarring from COVID-19. The study, launched with £2 million of funding from UK Research and Innovation (UKRI), aims to develop treatment strategies and prevent disability.